Suncare Traders Limited has appointed Mr. Ramesh Salvi as Whole-time Director and Chief Financial Officer effective July 21, 2026, subject to the approval of shareholders in the ensuing Annual General Meeting. The appointment follows the resignation of Mr. Harshad Rathod from the positions of Whole-time Director and Chief Financial Officer, also effective July 21, 2026, due to personal commitments.

Board Approval and Key Managerial Changes

The Board of Directors approved the appointment and resignation during a meeting that commenced at 03:15 PM and concluded at 03:30 PM on July 21, 2026. The intimation was submitted to BSE Limited pursuant to the second proviso to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Profile of the Appointee

Mr. Ramesh Salvi, 32 years old, brings five years of experience in the field of accounts and finance to the role. According to the initial disclosures under the SEBI (Prohibition of Insider Trading) Regulations, 2015, Mr. Salvi does not hold any shares in the company.

Resignation Details

Mr. Harshad Rathod resigned from his positions citing pre-occupation with other work. He confirmed that there are no other material reasons for his resignation other than those provided. Mr. Rathod holds directorships in one other listed entity.

Summary of Key Managerial Personnel Changes

Shree Ganesh Bio-Tech (India) Ltd has reduced its shareholding in Suncare Traders Ltd to 1.89% following the sale of 86,48,166 equity shares. The shares were sold via open market transactions between April 1 and June 22, 2026, according to a disclosure submitted under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Prior to the transaction, Shree Ganesh Bio-Tech held 1,34,58,166 shares, representing a 5.28% stake in the company. The acquirer does not belong to the promoter or promoter group of Suncare Traders. The total equity share capital of Suncare Traders remains Rs. 51,00,00,000, divided into 25,50,00,000 equity shares of Rs. 2 each.

The disclosure confirms that there were no changes to the company's equity structure or total voting capital as a result of the transaction. The diluted share capital also remains unchanged at Rs. 51,00,00,000. No shares were held under encumbrance or through warrants and convertible securities either before or after the sale.

Shareholding Details

The following table outlines the changes in shareholding patterns for Shree Ganesh Bio-Tech (India) Ltd:

The shares of Suncare Traders Ltd are listed on BSE Limited with the scrip code 539526.